確認メモ（原文・英語）Second Quarter 2026 Consolidated Financial Results (Summary) under IFRS, in English, 6 August 2026. Every quarter of 2024, 2025 and 2026 to date carries one.
確認メモ（原文・英語）Second Quarter 2026 Consolidated Financial Results (Summary) under IFRS, 6 Aug 2026: English 18 pages against the Japanese 2026年12月期 第2四半期（中間期）決算短信 at 19. The English carries the summary pages, the qualitative review (analysis of results, financial position, cash flows, forecast) and all four statements, but its notes stop at the segment tables. The Japanese notes section (pp.13-15) also carries the going-concern note, the segment overview with the sub-segment/main-products table, the measurement basis and the adjustment footnotes, and a full-page significant-subsequent-event note setting out the accounting for the Crasus Chemical spin-off (IFRS 5 / IFRIC 17 treatment). None of that is in English. The FY2025 tanshin (13 Feb 2026) shows the same pattern: English 21 pages against 24, with the impairment-loss, per-share and subsequent-event notes left in Japanese only. Part of the notes exists only in Japanese, so 3.
確認メモ（原文・英語）The English tanshin carry full statements of financial position, profit or loss, comprehensive income, changes in equity and cash flows for 1H 2026, but the only note is the segment table and its reconciliation to profit before tax. The year-end English tanshin (FY2025) is the same: no per-share note, impairment note or subsequent-event note, all of which the Japanese carries. No other current English source supplies notes: the English Financial Report series (with notes) ends at Financial Report 2022, there is no English securities report, and the RESONAC REPORT 2026 financial section is statements only. Statements without notes (the segment figures aside), so 3.
確認メモ（原文・英語）The English IR library runs to financial results, long-term vision reports, integrated reports and a 'Financial Report (Archive)' - and that archive holds the former Showa Denko annual reports to 2022, not securities reports. No annual securities report in English anywhere on the English site.
確認メモ（原文・英語）Every English tanshin carries revenue and segment profit (core operating profit) for the five reporting segments - Semiconductor and Electronic Materials, Mobility, Innovation Enabling Materials, Chemicals, Crasus Chemical - plus Others and adjustments; the 1H 2026 deck adds year-on-year and quarterly segment breakdowns, EBITDA margins, segment capex and depreciation, and a 'Main Products' page (p.29) defining what sits in each segment and sub-segment. Core operating profit is defined in the English tanshin (operating profit excluding non-recurring items, listed). Past periods are restated when the segments change (the deck shows 2025 on the current segments). Sales and profit by segment every period with definitions stated in English, so 5.
確認メモ（原文・英語）Two spreadsheet routes on the English IR site. 'Consolidated Financial Statements' offers Excel and PDF downloads (irpocket.com/4004/dl_2025/enfy_resonac.xlsx and enquarter_resonac.xlsx) of balance sheet, income statement and cash flow, J-GAAP 2020-2024 and IFRS 2023-2025, annual and quarterly. 'Performance Trends (Tool for financial analysis)' (Euroland) carries up to 11 years of statements of income, balance sheet, cash flow, major indicators, per-share data, key ratios and segment information with an 'Export all the data into an Excel' link. Five years and more of P&L, balance sheet, cash flow and per-share data, with segments, in Excel - 5. The IFRS series itself only runs from 2023; the longer history is J-GAAP.
確認メモ（原文・英語）The English 1H 2026 tanshin gives the revised full-year forecast (revenue ¥1,165.0bn, core operating profit ¥196.0bn, profit attributable ¥112.5bn) against the previous one, and the separate English release 'Resonac Revises Consolidated Earnings Forecast for FY2026' (6 Aug) explains it. The deck adds the basis: previous-versus-current forecast bridge with reasons (Crasus Chemical reclassified as discontinued operation, AI-related materials overperforming), segment forecasts for revenue and core operating profit (pp.16-17), financial indicators (p.18) and key variables - ¥/US$ 154.1 and ¥/Euro 179.8 forecast, domestic naphtha price (p.22). Forecast, assumptions, segment numbers and revision explained, so 5.
確認メモ（原文・英語）Resonac runs a long-term vision rather than a dated medium-term plan. The current presentation, 'Co-Creative Chemical Company - Reforms toward global top-level functional chemical company' (CEO, 13 Feb 2026), is in English at 31 pages, the same length as the Japanese 長期ビジョン deck, with webcast and Q&A. Its numerical targets: revenue above ¥1tn, EBITDA margin 20%, semiconductor/electronics at 50% or more of revenue, EV/EBITDA 15x, EBITDA ¥200bn, ROIC 10%, Net Debt/EBITDA 3.0x or less, 50%+ of operating cash flow to growth segments; RESONAC REPORT 2026 adds EPS ¥500 and a net D/E of 1.0x or less. Current, quantified, as complete as the Japanese - 5. The targets carry no fixed end year.
確認メモ（原文・英語）For each quarter: presentation materials, a Q&A summary and an archived conference webcast, all in English, running unbroken from 2024 to the latest quarter.
確認メモの要点（当調査による日本語要約）英文のRESONAC REPORT 2026冒頭の「At a Glance」がセグメント別の売上・利益、半導体材料5品目の世界シェアNo.1、5つの競争優位を示し、数値化された専用の章があるため5点です。
確認メモ（原文・英語）RESONAC REPORT 2026 (English) opens with 'At a Glance: What Does Resonac Do?' (pp.5-8): segment revenue, core operating profit and EBITDA margin with prior-year figures, revenue split by segment, 'No. 1 global share in five semiconductor materials', and five named competitive advantages (JOINT3/US-JOINT consortia, back-end evaluation platform, front-to-back material portfolio, AI x computational science, global support system). The site's 'Introductory Guide to the Resonac' page repeats the strengths with figures (28 companies in JOINT3, 12 in US-JOINT, four front-end and eight back-end products). A dedicated at-a-glance section with quantified strengths, so 5 - though it sits in the integrated report and About Us, not on an IR 'why invest' page.
確認メモ（原文・英語）The February 2026 long-term vision deck names the growth drivers and puts numbers on them: AI-related back-end semiconductor materials with a 25-50% CAGR expected, growth ranges by product (+80% or more, +60 to +150%, a 20% CAGR, +15 to +20%), segment revenue and core operating profit with target EBITDA margins (Semiconductor and Electronic Materials 30%, others 15%), semiconductor/electronics rising from 38% to 50%+ of revenue, and 50%+ of operating cash flow going to growth segments. The integrated report's business-strategy chapters repeat these by business. Named drivers with numbers attached, so 5.
確認メモ（原文・英語）Every results briefing has an English 'Summary of Questions and Answers' alongside the deck and webcast: 1Q and 2Q 2026 and every quarter of 2025, 2024 and 2023 back to 2018 on the Financial Results page. The Japanese side publishes the same document type (説明会Q&A要旨) and no full transcript; its 2Q 2026 Q&A is 1 page (1,708 characters) and the English is 1 page (4,274 characters), both dated 7 Aug 2026. The Japanese full-year video has no English version, but that is a medium, not content. A Q&A for every briefing the Japanese side covers, so 5.
確認メモ（原文・英語）RESONAC REPORT 2026, the current integrated report, in English in an interactive and a full-download edition, with English back numbers to 2018.
確認メモ（原文・英語）The vision deck (13 Feb 2026) opens with '2022 Long-Term Vision: Progress and Current Position': revenue ¥1.3tn against 'exceeding ¥1tn', EBITDA margin 15.1% against 20%, PBR 2.3x against 'exceeding 1x'. RESONAC REPORT 2026's CFO chapter sets each target against the actuals for 2022-2025 and the 2026 forecast - EBITDA margin (with an ex-olefins line), EPS, adjusted EPS, ROIC, net debt, net D/E, Net Debt/EBITDA. It explains the gaps: the petrochemical drag, the expected order of achievement (EBITDA margin, then EPS, then ROIC) and the path to each. A dated target-versus-actual reconciliation with the variances explained, so 5. The plan is the same continuing vision (Phase 1 to Phase 2), not a closed predecessor plan.
確認メモ（原文・英語）The Corporate Governance Report dated 27 March 2026 in English, alongside the Corporate Governance Basic Policies amended 5 March 2026. Both current.
確認メモ（原文・英語）The English Notice of Convocation of the 117th OGM (26 Mar 2026) gives every one of the nine director candidates - the whole board - a full profile: date of birth, 'Term of office as Director' in years, shares held, board attendance (e.g. 12/12), career history, concurrent posts and the reason for nomination, with Outside/Independent marked against each. The skill matrix repeats tenure in years for all directors and A&SB members. Tenure, expertise and independence for every director, so 5.
確認メモ（原文・英語）The English AGM notice (Feb 2026) carries the skill matrix for the board as constituted if Proposals 3 and 4 pass - nine directors and five A&SB members against eight skills (Global Business, Portfolio Management, Sustainability, Risk Management, Finance/Accounting/Capital Markets, Innovation, Personnel Development/Corporate Culture, Legal/Compliance) - with each skill's selection reason. The current matrix in English, so 5.
確認メモ（原文・英語）The English Corporate Governance page sets out the structure: base salary, STI, and LTI as PSU (3-year relative TSR, coefficient 0-240%, against 22 domestic chemical/textile peers and US/European sector indices) plus performance-linked RS (sustainability coefficient 85-115%), and RS for outside directors. It gives FY2025 amounts by type: directors ¥1,222m in total, of which basic ¥381m, STI ¥164m, PSU ¥512m and RS ¥144m/¥20m. RESONAC REPORT 2026 adds the STI KPIs and weights: EBITDA 20%, EBITDA margin 30%, ROIC 20%, personal evaluation 30%. It also gives the FY2023 LTI outcome: TSR coefficient 200% on a 301.4% three-year TSR. Structure, KPIs, weights and amounts, so 5.
確認メモ（原文・英語）Notice of Convocation of the 117th OGM, published 5 March 2026 for a meeting on 26 March - 21 days, voting open to 25 March - carrying the matters to be reported and all four proposals, with supplementary materials for Proposal No. 2 translated as well. Re-checked 23 Oct 2026 (G5 voting-site sweep, after the independent audit): the voting website named in the English notice, soukai.mizuho-tb.co.jp (Mizuho Trust & Banking), is in Japanese only, with no English option, as for ESPEC (6859) and Nitto Boseki (3110). Every proposal in English, but a Japanese-only voting route, so 4.
確認メモ（原文・英語）The English Shareholders' Meeting page lists convocation notices from the 102nd meeting to the 117th, plus supplementary materials and one notice of correction. No resolution notice and no voting-results report in English for any year.
確認メモ（原文・英語）RESONAC REPORT 2026's governance chapter: 'In principle, the Group adheres to a policy of not engaging in cross-shareholdings, and steps are currently underway to reduce existing cross-shareholdings'; 'We do not hold any listed shares as of June 30, 2026'. It gives 51 unlisted holdings at ¥1,751m, holdings reduced in FY2025 (12 unlisted, 1 listed, ¥166m proceeds), the one addition and its reason, the annual board review against capital cost, and the voting standard. The company states in English that it holds no listed cross-shareholdings, which the anchor scores 5.
確認メモ（原文・英語）Sampled 17 English document links across types; every one is English (no CJK text beyond stray characters): 1H and 1Q 2026 tanshin, 3Q 2025 tanshin, 1Q 2023 tanshin, 3Q 2012 tanshin, 1H and 1Q 2026 decks, 1H and 1Q 2026 Q&A summaries, a 2020 full-year item, Financial Report 2022 (52pp), Annual Report 2018 (50pp), 117th and 115th AGM notices, the Proposal 2 supplementary materials, the Articles of Incorporation (2 Oct 2026), the CG Report (27 Mar 2026, 40pp), RESONAC REPORT 2026 (72pp), the 6 Oct 2026 news release and the JOINT3 IR material. All English, so 5.
確認メモ（原文・英語）The same sample of 17 document links (2012 to Oct 2026: tanshin, decks, Q&A, financial/annual reports, AGM notices, articles, CG report, integrated report, news) all opened and rendered with page counts. No dead links, so 5.
確認メモ（原文・英語）Rendered in Chromium: IR top (live stock quote, news, IR menu), Financial Results, Long-term Vision Reports, Shareholders' Meeting, Consolidated Financial Statements (irpocket tables), Performance Trends (Euroland chart tool), Summary of Financial Data, IR Calendar (Euroland iframe: timeline, next event 11 Nov 2026), Stock Price Chart (iframe quote table), Governance and Integrated Report pages. All rendered their content; the calendar and chart pages are blank in text extraction but render in screenshots. 5.
確認メモ（原文・英語）No single library. Documents are split by type across several pages, each dated: Financial Results (a period grid of tanshin, deck, Q&A, CEO material and webcast by quarter), Long-term Vision Reports (dated), Integrated Reports, Financial Report (Archive), Shareholders' Meeting (notices by meeting number) and IR Webcasts. The general News list has a 'Management / IR' filter, but it is a news feed, not a document library. Split across pages by type, each dated - 3.
確認メモ（原文・英語）Deep archive: tanshin and decks by quarter from 2012 (Q&A summaries and webcasts from 2018) through 1H 2026, annual and financial reports from 2017 to 2022, integrated reports back to 2018, AGM notices from the 113th (2022) to the 117th, and vision presentations from 2020. Several years across document types, so 5.
確認メモ（原文・英語）The English Contact Us page has a dedicated Investor Relations enquiry form and a second one for individual investors - a real route - but no person and no department is named, and the English results summary carries no contact header. The question asks for a named contact; there is none.
確認メモ（原文・英語）The English and Japanese news lists date the results the same day each period: 3Q 2025 tanshin and deck 13 Nov 2025 both; FY2025 13 Feb 2026 both; 1Q 2026 13 May 2026 both; 1H 2026 6 Aug 2026 both. PDF creation dates agree: 1H English tanshin and deck created 6 Aug against Japanese 5-6 Aug; FY2025 English tanshin 13 Feb against Japanese created 12 Feb, modified 13 Feb. Tanshin and deck in English the same day, every period, so 5.
確認メモ（原文・英語）Lags English vs Japanese: 1H 2026 tanshin 6 Aug / 6 Aug = 0; 1Q 2026 13 May / 13 May = 0 (news-list dates); 117th AGM notice listed 26 Feb 2026 in both news lists = 0; Corporate Governance Report dated 27 Mar 2026 in both, both files in the 2026-04 upload folder (Japanese PDF created 7 Apr, English modified 8 Apr) = about 0-1; annual securities report: no English version = >90. Sorted 0, 0, 0, 0-1, >90 - median 0 days, so 5.
確認メモ（原文・英語）Twelve months to 14 Oct 2026: the Japanese news list has 32 '経営・決算' items and the English 'Management / IR' list has 30, all same-day. They match one for one: results and decks each quarter, forecast revisions (13 May, 6 Aug), articles amendment, board candidates, graphite rationalisation, the Crasus Chemical spin-off series (update, resolution, listing approval, distribution ratios, reference price, listing, completion), change in major shareholder, treasury-share disposal, untraceable-shareholder purchase, and convertible-bond conversion price adjustments. Two are missing in English: the 23 Mar 2026 Mizuho transition-loan announcement, and the 12 Mar AGM dispatch reminder, whose notice itself is in English from 26 Feb. Neither is a forecast, dividend, buyback, M&A or management-change disclosure. All timely disclosures, same day - 5. Compared against the company's own Japanese news list, not TDnet.
確認メモ（原文・英語）Rendered English homepage, IR top, Financial Results, Disclaimer, Terms of Use and 'How to use our IR website': no machine- or AI-translation notice anywhere, and no translation banner. The IR disclaimer covers forward-looking statements and TDnet precedence only. 5.
確認メモ（原文・英語）Silent, which is rare. The results summary carries no prevailing-language clause at all, and the AGM notice is headed only 'TRANSLATION' - no statement that the Japanese original governs, and none that the English does.
Resonac disclosed a 2026 execution objective, distribution of Crasus shares and a retained stake below 20%; by May it had amended its articles and submitted a TSE listing application.
時系列と出典（2件・内容は原文）
2026-02-13Execution structure disclosed Resonac described the planned partial spin-off, shareholder distribution and sub-20% retained stake.出典資料1
2026-04-01（公表 2026-05-13）Listing application submitted The company reported corporate approvals and an April TSE listing application.出典資料1
経営陣が表明したこと
Resonac said it would partially spin off and list Crasus in 2026, distribute Crasus shares and retain less than 20%.
Investor question: What are the pro forma value, cash and leverage effects? IR preparation: disclose closing conditions, separation costs and both companies’ capital policies.
当調査の分析（会社の説明ではありません）
約束は具体的か4／5Structure, timing objective and retained stake are disclosed, but valuation and detailed closing terms are not.
実行の経過を追えるか4／5Corporate approvals and the listing application demonstrate traceable progress.
経済性を説明しているか3／5Strategic portfolio rationale is clear; pro forma economics and separation costs are incomplete.
目標に対する結果を報告しているか時期未到来The calendar-2026 execution objective was not due at the as-of date.